[Neuropsychological changes in drug addicts infected with human immunodeficiency virus]. 1992

P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
Unidad de Desintoxicación de Drogodependientes, Hospital Psiquiátrico, Madrid.

The early organic mental disorder, caused by the human immunodeficiency virus type 1 (HIV) in the drug dependents (DD), if it is not taken into account, can disturb the diagnosis of the neuropsychiatric and the toxic disorders. The authors attempt to outline, with several neuropsychological tests (visuo-perceptual, memory, attention) and with the physical and neurologic exploration, if cognitive abnormalities are present in two groups of DD after detoxification period. The first group is infected by the HIV (n: 48), and the second one is not (n: 33). Differences can be found only in the Bender visuo-perceptual test, which are not justified by the divergences found between the groups about the drug dependence history and the present drug of abuse intake. The importance of the early diagnosis of these abnormalities is argued in order to get a suitable treatment of the possible neuropsychiatric complications in the DD development, and restrain the extent of the cognitive damage by HIV infection.

UI MeSH Term Description Entries
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006556 Heroin Dependence Strong dependence or addiction, both physiological and emotional, upon HEROIN. Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
August 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
January 2008, Journal of addictive diseases,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
July 1989, Journal of chemotherapy (Florence, Italy),
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
January 1996, Acta neuropathologica,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
February 1997, International journal of STD & AIDS,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
December 1997, Epidemiology and infection,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
October 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
September 1988, Presse medicale (Paris, France : 1983),
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
October 1989, Medicina clinica,
P Sopelana, and M Débora, and S López-Calvo, and J C García-Alvarez, and C Polo
January 1993, Medicina clinica,
Copied contents to your clipboard!